Archive: July 2016
A recent study showed the number of specialty drugs filled from 2003 to 2014 tripled, causing U.S. insurers’ to nearly quadruple specialty drug spending. The Centers for Medicare and Medicaid Services (CMS) define specialty drugs as medications costing $600+ per month. According to Health Affairs, commercial insurance plan spending climbed 32% over that period. The number of specialty prescription drugs filled also rose from .6% to 1.8%, showing the need for Medication Therapy Management now more than ever.
Provider-influenced issues such as prescriptions for ineffective drugs, incorrect doses or potentially harmful drug-drug interactions, account for 70-75% of primary care medication-related problems, according to Marie Smith, PharmD, a professor at the University of Connecticut School of Pharmacy while speaking at the Medical Home Summit
[By Kent Holdcroft, SVP of Sales & Marketing] Centers for Medicare and Medicaid Services (CMS) recently reported in their June 16th blog that patients who are eligible for both Medicare and Medicaid and have access to health plans that offer integrated care between both programs have improved health outcomes.
We recently returned from Scottsdale, AZ where we had the opportunity to exhibit and attend the RISE Leadership Summit. The conference had three events all under one roof, the Star Ratings Strategic Planning Forum, the HEDIS Forum, and the CAHPS, HOS & Member Survey Forum.